Capsugel Logo
US English CN 简体中文 JP 日本語 ES Español PT Português
Log In
Hard Empty Capsules Portfolio
Equipment

Pharmaceutical From Standard to Specialist Capsule Formats Hard gelatin, HPMC, inhalation and vaginal formats engineered for every therapeutic need.

View all →

Hard Empty Capsules Portfolio
Ingredients
Equipment

Nutraceutical Consumer-Ready Nutraceutical Formats Capsules and branded ingredients built for supplement manufacturers who demand differentiation.

Explore range →

Pharmaceutical CDMO Services

Pharmaceutical CDMO

Accelerating Drug Development

Our Innovaform Accelerator and Tampa facility combine formulation science with scalable manufacturing.

Explore pharma CDMO →

Nutraceutical CDMO Services
Advanced Capsule Technologies

CDMO Partnership

Full-Service Nutraceutical Manufacturing

From concept to market-ready product — your end-to-end nutraceutical development partner.

Learn more →

Applications
Resources & Support
Company

Our Story

Partners in Drug Delivery Innovation

A global leader in capsule technologies, committed to advancing pharmaceutical and nutraceutical science.

Learn about Capsugel →

News & Media

Filter by News Category
Lonza Capsugel’s Licaps® DUOCAP® technology delivers up to four times the enzyme activity of standard capsules in peer-reviewed study
May 28, 2026, 7:00 AM
New peer reviewed research published in Pharmaceutics demonstrates that Lonza Capsugel’s Licaps® DUOCAP® capsule in capsule technology can significantly improve protection and targeted delivery of acid sensitive enzymes in the gastrointestinal (GI) tract
Lonza Capsugel strengthens global renewable energy strategy with local wind power agreement
May 20, 2026, 7:00 AM
Lonza Capsugel strengthens global renewable energy strategy by integrating local wind power into hard empty capsule manufacturing operations at its Bornem (BE) site through long term power purchase agreement.
NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms
Jan 19, 2021, 6:00 AM
Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage...
Lonza Has Received All Regulatory Approvals to Move Forward with Acquisition of Capsugel
Jun 27, 2017, 5:30 AM
Basel, Switzerland, 27 June 2017 – Lonza today announced that it has received all regulatory approvals for the proposed acquisition of Capsugel S.A. by Lonza. With all final...
Lonza akquiriert Capsugel, um führenden Anbieter von integrierten Lösungen für die globale Pharma- und Consumer-Healthcare-Branche zu schaffen
Dec 15, 2016, 5:30 AM
Strategische VorteileLonza akquiriert Capsugel für USD 5.5 Milliarden, einschliesslich der Refinanzierung bestehender Schulden von Capsugel in Höhe von USD ~2 MilliardenDie...
Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries
Dec 15, 2016, 5:30 AM
Strategic AdvantagesLonza to acquire Capsugel for USD 5.5 billion, including refinancing of existing Capsugel debt of USD ~2 billionAcquisition is expected to accelerate Lonza's...
Lonza Confirms Interest in Capsugel
Dec 12, 2016, 7:39 AM
Basel, 12 December 2016 – Lonza Group Ltd notes the recent press speculations that it is in final negotiations with KKR regarding the potential acquisition of Capsugel. Lonza...
Contact Us